AstraZeneca PLC (AZN) earnings: date, estimates, results and stock reactions
Next earnings: Q4 FY2026 on 2027-02-11 (expected, time not announced). EPS estimate 1.76, revenue estimate 12.60B.
Over the last 12 reports the stock moved 3.8% on average (either way), rising 10 times and falling 2. EPS beat estimates 10 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).
| Quarter | Reported | EPS | EPS estimate | EPS surprise | Revenue | Revenue estimate | Stock move |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 2026-10-30 | 2.10 | 1.95 | +7.7% | 12.22B | 12.07B | +6.2% |
| Q2 FY2026 | 2026-07-27 | 1.98 | 1.87 | +5.9% | 11.60B | 11.64B | +2.1% |
| Q1 FY2026 | 2026-04-29 | 1.90 | 1.86 | +2.2% | 11.26B | 11.30B | +0.3% |
| Q4 FY2025 | 2026-02-10 | 1.55 | 1.53 | +1.3% | 11.36B | 11.46B | +6.7% |
| Q3 FY2025 | 2025-11-06 | 1.81 | 1.74 | +4.0% | 11.29B | 11.25B | +3.6% |
| Q2 FY2025 | 2025-07-29 | 1.63 | 1.63 | +0.0% | 10.89B | 10.61B | +6.6% |
| Q1 FY2025 | 2025-04-29 | 1.87 | 1.68 | +11.3% | 10.50B | 10.39B | +1.9% |
| Q4 FY2024 | 2025-02-06 | 1.69 | 1.67 | +1.2% | 11.90B | 11.49B | +4.3% |